SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 28.1 EUR 1.59%
Market Cap: 4.2B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

SCHOTT Pharma AG & Co KgaA
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCHOTT Pharma AG & Co KgaA
Cash from Financing Activities Peer Comparison

Comparables:
E
EVT
GXI

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Cash from Financing Activities
-€11.4m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Evotec SE
XETRA:EVT
Cash from Financing Activities
-€63.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gerresheimer AG
XETRA:GXI
Cash from Financing Activities
€4.7m
CAGR 3-Years
N/A
CAGR 5-Years
-49%
CAGR 10-Years
N/A

See Also

What is SCHOTT Pharma AG & Co KgaA's Cash from Financing Activities?
Cash from Financing Activities
-11.4m EUR

Based on the financial report for Sep 30, 2023, SCHOTT Pharma AG & Co KgaA's Cash from Financing Activities amounts to -11.4m EUR.

What is SCHOTT Pharma AG & Co KgaA's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
8%

Over the last year, the Cash from Financing Activities growth was 73%. The average annual Cash from Financing Activities growth rates for SCHOTT Pharma AG & Co KgaA have been 8% over the past three years .

Back to Top